Patents by Inventor Natsuki ONO

Natsuki ONO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240110364
    Abstract: A pump control device and a valve control device each includes: an instruction calculator that calculates a control instruction of causing a controlled object to operate by using a manipulation amount of a manipulation and at least one control parameter, and inputs the calculated control instruction to the controlled object; and an ideal output calculator that calculates an ideal output of an actuator, the ideal output being associated with the manipulation amount of the manipulation. The pump control device adjusts at least one pump control parameter to reduce a difference between a control output and the ideal output when an operation of a movable part is a power running operation. The valve control device adjusts at least one valve control parameter to reduce a difference between a control output and the ideal output when the operation of the movable part is a non-power running operation.
    Type: Application
    Filed: December 21, 2021
    Publication date: April 4, 2024
    Applicants: KOBELCO CONSTRUCTION MACHINERY CO., LTD., HIROSHIMA UNIVERSITY
    Inventors: Kazushige KOIWAI, Yohei ONO, Natsuki YUMOTO, Shin WAKITANI, Toru YAMAMOTO
  • Publication number: 20230272099
    Abstract: An objective of the present disclosure is to provide: anticancer agents having an immune cell-activating effect, a cytotoxic activity, or an antitumor activity, but having a low effect on non-tumor tissues such as normal tissues and having few side effects; combination therapies using those anticancer agents and other anticancer agents; and pharmaceutical combinations for use in those combination therapies. Anticancer agents expected to be applied to various types of cancers, which have an immune cell-activating effect, a cytotoxic activity, or an antitumor activity while having a low effect on non-tumor tissues such as normal tissues and having few side effects by using as an active ingredient an anti-CD137 antigen-binding molecule of the present disclosure, the binding activity of which to CD137 changes depending on various substances (for example, low molecular weight compounds) in target tissues, are provided.
    Type: Application
    Filed: February 10, 2021
    Publication date: August 31, 2023
    Inventors: Mika SAKURAI, Yoshinori NARITA, Kenji TANIGUCHI, Hirofumi MIKAMI, Sayuri HORIKAWA, Ryo UCHIKAWA, Natsuki ONO, Koki HAMADA